BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

33 related articles for article (PubMed ID: 18221688)

  • 1. Age-related dynamic embolic risk in patients with nonvalvular atrial fibrillation.
    González-Fernández D; Raposeiras-Roubín S; González-García A; Iglesias-Otero C; Íñiguez-Romo A; Abu-Assi E
    Rev Esp Cardiol (Engl Ed); 2024 May; 77(5):429-430. PubMed ID: 38104927
    [No Abstract]   [Full Text] [Related]  

  • 2. CHADS 2 Scores in the Prediction of Major Adverse Cardiovascular Events in Patients with Cushing's Syndrome.
    Wang YF; Chuang MH; Chuang TL; Huang KY; Lyu SR; Huang CY; Lee CC
    Int J Endocrinol; 2014; 2014():138653. PubMed ID: 25101124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting Thromboembolic and Bleeding Event Risk in Patients with Non-Valvular Atrial Fibrillation: A Systematic Review.
    Borre ED; Goode A; Raitz G; Shah B; Lowenstern A; Chatterjee R; Sharan L; Allen LaPointe NM; Yapa R; Davis JK; Lallinger K; Schmidt R; Kosinski A; Al-Khatib SM; Sanders GD
    Thromb Haemost; 2018 Dec; 118(12):2171-2187. PubMed ID: 30376678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Angiotensin-Converting Enzyme Inhibition on Circulating Endothelial Progenitor Cells in Patients with Acute Ischemic Stroke.
    Gołąb-Janowska M; Paczkowska E; Machaliński B; Kotlęga D; Meller A; Safranow K; Maj M; Nowacki P
    Stem Cells Int; 2018; 2018():2827580. PubMed ID: 29853909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. To anticoagulate or not to anticoagulate? That is the question : A Medline-based quantitative approach to share evidence on common clinical problems.
    Birocchi S; Cernuschi G; Podda GM; Costantino G
    Intern Emerg Med; 2013 Apr; 8(3):245-8. PubMed ID: 22847728
    [No Abstract]   [Full Text] [Related]  

  • 6. Improving stroke risk stratification in atrial fibrillation.
    Lip GY; Halperin JL
    Am J Med; 2010 Jun; 123(6):484-8. PubMed ID: 20569748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes and safety of antithrombotic treatment in patients aged 80 years or older with nonvalvular atrial fibrillation.
    Ruiz Ortiz M; Romo E; Mesa D; Delgado M; Ibáñez CL; Anguita M; Castillo JC; Arizón JM; Suárez de Lezo J
    Am J Cardiol; 2011 May; 107(10):1489-93. PubMed ID: 21420049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
    Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
    J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of bleeding in very old atrial fibrillation patients on warfarin: relationship with ageing and CHADS2 score.
    Poli D; Antonucci E; Marcucci R; Fatini C; Alterini B; Mannini L; Falciani M; Abbate R; Gensini GF; Prisco D
    Thromb Res; 2007; 121(3):347-52. PubMed ID: 17597186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral anticoagulation in nonvalvular atrial fibrillation in clinical practice: impact of CHADS(2) score on outcome.
    Ruiz Ortiz M; Romo E; Mesa D; Delgado M; Anguita M; Castillo JC; Arizón JM; Suárez de Lezo J
    Cardiology; 2010; 115(3):200-4. PubMed ID: 20160440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitored atrial fibrillation duration predicts arterial embolic events in patients suffering from bradycardia and atrial fibrillation implanted with antitachycardia pacemakers.
    Capucci A; Santini M; Padeletti L; Gulizia M; Botto G; Boriani G; Ricci R; Favale S; Zolezzi F; Di Belardino N; Molon G; Drago F; Villani GQ; Mazzini E; Vimercati M; Grammatico A;
    J Am Coll Cardiol; 2005 Nov; 46(10):1913-20. PubMed ID: 16286180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Predicting embolic events in patients with nonvalvular atrial fibrillation: evaluation of the CHADS2 score in a Mediterranean population].
    Ruiz Ortiz M; Romo E; Mesa D; Delgado M; Anguita M; López Granados A; Castillo JC; Arizón JM; Suárez de Lezo J
    Rev Esp Cardiol; 2008 Jan; 61(1):29-35. PubMed ID: 18221688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Atrial fibrillation: incidence and prognostic factors of embolic risk].
    Di Pasquale G; Ribani MA; Urbinati S; Passarelli P; Pinelli G
    Cardiologia; 1993 Dec; 38(12 Suppl 1):291-300. PubMed ID: 8020029
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.